C91: N-(naphthalen-2-yl)-2-[2-(pyridin-2-yl)-1H-benzimidazol-1-yl]acetamide
C91 is a Ligand Of Interest in 4MY9 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4MY9_C91_E_501 | 51% | 30% | 0.185 | 0.939 | 1.71 | 1.12 | 8 | 4 | 0 | 0 | 100% | 1 |
| 4MY9_C91_A_501 | 48% | 29% | 0.205 | 0.951 | 1.7 | 1.15 | 9 | 4 | 0 | 0 | 100% | 1 |
| 4MY9_C91_H_501 | 43% | 29% | 0.224 | 0.95 | 1.71 | 1.15 | 8 | 4 | 0 | 0 | 100% | 1 |
| 4MY9_C91_B_501 | 43% | 29% | 0.229 | 0.953 | 1.71 | 1.14 | 8 | 4 | 1 | 0 | 100% | 1 |
| 4MY9_C91_F_501 | 34% | 30% | 0.246 | 0.931 | 1.69 | 1.12 | 8 | 4 | 0 | 0 | 100% | 1 |
| 4MY9_C91_D_501 | 31% | 31% | 0.268 | 0.94 | 1.69 | 1.06 | 8 | 4 | 0 | 0 | 100% | 1 |
| 4MY9_C91_G_501 | 31% | 30% | 0.261 | 0.929 | 1.71 | 1.1 | 8 | 4 | 0 | 0 | 100% | 1 |
| 4MY9_C91_C_501 | 30% | 30% | 0.278 | 0.943 | 1.68 | 1.14 | 8 | 4 | 0 | 0 | 100% | 1 |
| 4MZ8_C91_B_502 | 61% | 27% | 0.165 | 0.956 | 1.78 | 1.2 | 11 | 5 | 1 | 0 | 100% | 1 |
| 4Q32_C91_D_501 | 31% | 30% | 0.264 | 0.932 | 1.71 | 1.08 | 8 | 4 | 0 | 0 | 100% | 1 |
